Clinical Trial Update: Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer [Phase 1]

View source ↗

Summary

Phase 1 safety study of an antisense product in multiple cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Prostate Cancer

Drugs mentioned

• Antisense product

Snippet

Sponsor: Achieve Life Sciences | Conditions: Neoplasms | Phase 1 | Status: COMPLETED